Lupin Limited has informed the Exchange regarding a press release dated August 12, 2025, titled "Lupin Announces Licensing Deal for Ranibizumab Biosimilar".
Lupin Limited has informed the Exchange regarding a press release dated August 12, 2025, titled "Lupin Announces Licensing Deal for Ranibizumab Biosimilar".